The company
Avita Medical, Inc.
RCEL · Nasdaq
RCEL stood above a rising 150-day average in 17 of the last 52 weekly readings, including each of the last 17 weeks. It is 127.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 17 in a row
- Industry in uptrend
- 29% -4 in 4 wk
- Insider buys, 12 months
- $469K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 1
- Institutions holding
- 70 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 0, Senate 0, executive 1; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Keith Sonderling Executive branch: Office of Government EthicsDepartment of Labor | sold | $1k–$15k | 28 Mar 2025filed 14 May 2025 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David D. O'TooleCFO | bought | 2,000at $3.97 | 12 Jun 2026filed 24 Aug 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.20 | 9 Jun 2026filed 9 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.18 | 9 Jun 2026filed 9 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,200at $4.00 | 9 Jun 2026filed 10 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.10 | 3 Jun 2026filed 5 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.09 | 3 Jun 2026filed 5 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.18 | 2 Jun 2026filed 3 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.21 | 2 Jun 2026filed 3 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.34 | 1 Jun 2026filed 3 Jun 2026 |
| Joseph Fralin WoodyDirector | bought | 5,000at $4.26 | 1 Jun 2026filed 3 Jun 2026 |
| David D. O'TooleCFO | bought | 2,000at $4.26 | 20 May 2026filed 20 May 2026 |
| David D. O'TooleCFO | bought | 2,000at $4.24 | 19 May 2026filed 19 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,333,914$5.5M | -1,238−0.1% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 564,952$2.3M | -568,174−50.1% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 339,822$1.4M | -203,152−37.4% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 338,387$1.4M | +285,825+543.8% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 321,013$1.3M | +226,652+240.2% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 200,462$828K | +42,841+27.2% |
| VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026 | 182,402$753K | -11,034−5.7% |
| NewEdge Advisors, LLCnew · filed 12 Aug 2026 | 148,931$615K | +148,931 |
| MACQUARIE GROUP LTDadded · filed 14 Aug 2026 | 144,164$595K | +132,262+1111.3% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 128,977$533K | -300,045−69.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.